Amylin Pharmaceuticals (AMLN)
Amylin Pharmaceuticals Revenues: 153.69M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AMLN Revenues Rankings
| Overall | 55th percentile | 1968 of 4425 |
| Sector | 72nd percentile | 127 of 470 in Healthcare |
| Industry | 91st percentile | 11 of 132 in Biotechnology |
AMLN Revenues Range, Past 5 Years
| Minimum | 132.01M | Dec 2008 |
| Maximum | 222.02M | Jun 2008 |
| Average | 177.50M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these AMLN related companies
AMLN News
$AMLN low 30's easy on tues. Followed by buyout in mid to upper 30's
about 2 days ago by QR_Winner
about 2 days ago by QR_Winner
Sara Lee, Amylin Pharmaceuticals Included in Stocks Up on High Volume Friday
May 25, 4:34PM Fox Business
May 25, 4:34PM Fox Business
RT @markflowchatter Great alert by @TradeHawk on $AMLN as usual,recall that alot of the firms think a deal gets done at $30 - $37
about 2 days ago by epime7heus
about 2 days ago by epime7heus
RT @epime7heus everyone picking up some $AMLN in case of buyout just before or after holiday weekend <----- 3:30 pm yesterday
about 2 days ago by epime7heus
about 2 days ago by epime7heus
RT @tiernster $AMLN news says they received bids of at least $25? better b more then that - this is the 3rd time buyout talks increased pps
about 2 days ago by jackofalltrade
about 2 days ago by jackofalltrade
$AMLN news says they received bids of at least $25? better b more then that.
about 2 days ago by tiernster
about 2 days ago by tiernster
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
May 25, 2:01PM Street Insider
May 25, 2:01PM Street Insider
everyone picking up some $AMLN in case of buyout just before or after holiday weekend
about 3 days ago by epime7heus
about 3 days ago by epime7heus
RT @adamfeuerstein $AMLN Bydureon scripts flatfor the week although Victoza down 2.5% - scripts always seem to be highest first week of mth
about 6 days ago by jackofalltrade
about 6 days ago by jackofalltrade
$AMLN http://stks.co/3uVP Careful adding to the long. Divergence between MACD and Price action.
about 7 days ago by abdulalikon
about 7 days ago by abdulalikon
perfect time to sneak an $AMLN buyout in would be tomorrow before $FB opens at 11am
about 9 days ago by epime7heus
about 9 days ago by epime7heus
$AMLN http://stks.co/3qmJ could accelerate if it breaks out of rising wedge... http://stks.co/3qmK
about 11 days ago by TraderHR
about 11 days ago by TraderHR
Colgate-Palmolive, Amylin Pharmaceuticals, Other Stocks Hit 52-Week Highs Tuesday
May 15, 12:32PM Fox Business
May 15, 12:32PM Fox Business
Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference
Apr 30, 4:21PM Business Wire
Apr 30, 4:21PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMLN | 27.96 | +2.16 | +8.37% | 4.496B |
| AMKR | 4.65 | +0.07 | +1.53% | 782.83M |
| AMJ | 37.36 | +0.23 | +0.62% | |
| AMIC | 4.35 | -0.34 | -7.25% | 35.97M |
| AMGN | 69.05 | -0.05 | -0.07% | 54.16B |
| AMG | 103.47 | -0.33 | -0.32% | 5.356B |
| AME | 49.22 | -0.44 | -0.89% | 7.911B |
| AMD | 6.22 | +0.20 | +3.32% | 4.350B |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AINV | 7.46 | -0.03 | -0.40% | 1.470B |
